# Tyrosine Kinase Inhibitors and Low Intensity Chemotherapy in Ph+ ALL

> **NCT02888977** · — · UNKNOWN · sponsor: **Versailles Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Lymphoblastic Leukemia, Acute

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02888977
- **Lead sponsor:** Versailles Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-12
- **Primary completion:** 2020-12
- **Final completion:** 2022-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2018-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02888977

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02888977, "Tyrosine Kinase Inhibitors and Low Intensity Chemotherapy in Ph+ ALL". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02888977. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*